Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review
Bispecific antibodies have emerged as a promising class of therapeutics in the field of oncology, offering an innovative approach to target cancer cells while sparing healthy tissues. These antibodies are designed to bind two different antigens, enabling them to bridge immune cells with cancer cells...
Saved in:
Main Authors: | Atulya Aman Khosla (Author), Karan Jatwani (Author), Rohit Singh (Author), Aswanth Reddy (Author), Ishmael Jaiyesimi (Author), Aakash Desai (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bispecific antibodies in cancer immunotherapy
by: Eva Dahlén, et al.
Published: (2018) -
Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017) -
Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer
Published: (2023) -
Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy
by: Xiaojing Qin, et al.
Published: (2024) -
Bispecific antibodies in cancer therapy: Target selection and regulatory requirements
by: Yanze Sun, et al.
Published: (2023)